The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines classify a patient's COPD and provide recommendations for first-line treatment. The 2021 update included information regarding the use of e-cigarettes as nicotine replacement, triple therapy, and how the SARS-CoV-2 virus impacted patients with COPD. Exacerbations are a hallmark feature of COPD and contribute to morbidity and mortality. There is general agreement that the pharmacotherapy of COPD exacerbations includes bronchodilators, corticosteroids, and antibiotics. Strong evidence exists for the benefit of corticosteroids for exacerbations and of antibiotics in the acute hospital setting. There remains considerable uncertainty, however, in the best drug selection, dose, route, and duration of treatment. Guidance Next This guideline sets out an antimicrobial prescribing strategy for acute exacerbations of chronic obstructive pulmonary disease (COPD). It aims to optimise antibiotic use and reduce antibiotic resistance. COPD Guidelines: The COPD-X plan Version 2.65, December 2022 Lung Foundation Australia's COPD Guidelines Committee, manages the co-branded Lung Foundation and Thoracic Society of Australia and New Zealand's, "The COPD-X Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease". To ensure you stay up-to-date with these guidelines, register The Global Initiative for Chronic Obstructive Lung Disease (GOLD), a report produced by the National Heart, Lung, and Blood Institute (NHLBI) and the World Health Organization (WHO), defines an exacerbation of chronic obstructive pulmonary disease (COPD) as "an acute event characterized by a worsening of the patient's respiratory symptoms that is beyond normal day-to-day variations and leads to a change in medication" . This generally includes an acute change in one or more of the following Prevention of exacerbations is a key objective in chronic obstructive pulmonary disease (COPD) evidence has been described in detail in the previous ERS/ATS guideline on management of COPD exacerbations [6], and can also be found in the supplementary material. February 2013 and September 2015. We used the same or similar search exacerbations has not been a major focus until recently. Most current COPD guidelines focus on the general diagnosis and evaluation of the patient with COPD, the management of stable disease, and the diagnosis and management of acute exacerbations. 1 , 20 Although current COPD guidelines state that prevention of ALAT-2014 COPD Clinical Practice Guidelines used clinical questions in PICO format to compile evidence related to risk factors, COPD screening, disease prognosis, treatment and exacerbations. Evidence reveals the existence of risk factors for COPD other than tobacco, as well as gender differences in … The aim of the study was to identify criteria recommended in current COPD guidelines for treating acute exacerbations with systemic corticosteroids and antibiotics and to assess the underlying INTRODUCTION. An exacerbation of chronic obstructive pulmonary disease (COPD) is defined as "an acute event characterized by a worsening of the patient's respiratory symptoms that is beyond normal day-to-day variations and leads to a change in medication" by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), a report produced by approximately 50% of copd exacerbation events are associated wi